FDA Reverses Stance on Removal of Morphine Painkiller (HealthCentral)
Appeals from hospice experts mean an unapproved drug, one of 14 given recent warning, will remain on the market, agency says.

FDA Obtains Permanent Injunction Barring Two Companies from Manufacturing and Distributing Unapproved Drugs (U. S. Food and Drug Administration)
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.

FDA Adopts Interim Plan to Avoid Shortage of Medically Necessary Opioid (U. S. Food and Drug Administration)
The U.S Food and Drug Administration today amended its March 30, 2009, action warning manufacturers to stop the production and distribution of certain unapproved prescription opioids, to allow the continued marketing and distribution of one particular type of opioid -- a high concentrate morphine sulfate oral solution -- on an interim basis.